Successful downregulation of MYC mRNA and protein has been demonstrated using LipofectamineTM-mediated delivery of siRNA in colon cancer cells, leading to proliferation inhibition, induction of apoptosis, and cell growth suppression (166). This evidence concerns the gene MYC and colonic neoplasm.